Early Detection of Gynecologic Cancers Through Vaginal Fluid Analysis
Starting with ovarian cancer:
a lethal, aggressive cancer that strikes without warnings
Who we are
Women • Health • First
Nevia Bio is a diagnostics company focused on transforming early detection, monitoring and treatment guidance for gynecological cancers. By harnessing the unique biological properties of vaginal fluid as a liquid biopsy, we aim to deliver earlier, more accurate, and more accessible diagnostic solutions—starting with ovarian cancer and expanding to the full spectrum of gynecological malignancies.
​
Using AI and a multi-omics approach, we are challenging conventional assumptions in cancer care and pioneer a novel, proximity-based, non-invasive approach that gives women better outcomes, more time, and greater agency over their health.
Our
Solution
Simple vaginal swab
Biomarkers data
Nevia Bio uses vaginal fluid—not blood—to detect gynecologic cancers earlier and more accurately. By analyzing the fluid nearest to the tumor site, rather than waiting for cancer DNA to appear in blood, we aim to uncover disease much sooner.
Our test is designed for self-collection, eliminating the need for blood draws, clinical visits, or invasive procedures. The result: earlier and more accurate detection, with lower cost and higher convenience
Machine learning
Identify patients
Team
CEO
Director of Partnerships
Scientific Project Manager &
Regulatory Affairs Specialist
Dekel Gelbman, LL.B, MBA
Shiri Blumenfeld Kan, PhD, MBA
Nicole Fleischer, BSc, MBA
Clinial Operations Manager
Valeria Miller, BSc, MBA
Senior Scientist, Life Science
Yael Teboul, MSc
Senior Data Scientist
Zohar Shnaider, BSc
Board of Directors
Chair of the board
Founder, CSO & Director
Anula Jayasuriya MD, PhD, MBA
Shlomit Yehudai Reshef, PhD
Director & Co-founder
Inbal Zafir Lavie, PhD
Board member
Dr. Orna Berry
Board member
Board observer
Hila Karah
Iris Beck
Scientific Advisory Board
Prof. Rob Coleman
Chief Medical Officer, Vaniam Group, GOG Partners, Special Advisor to the President, GOG Foundation, Board Of Directors
Prof. Brian Slomovitz
Director, Gynecologic Oncology and Co-Chair, Cancer Research Committee, Mount Sinai Medical Center, Board of Directors and Uterine Cancer Lead, GOG Foundation
Prof. Ruth Perets
Medical Oncologist and Head of the Women's Cancers Research Lab at Rambam Health Care Campus. Directs the Phase 1 Clinical Trials in Oncology
Prof. Eitan Friedman
Director and founder of the The Suzanne Levy-Gertner Oncogenetics Unit at the Sheba Medical Center
Why Us
Part of Israel's Innovation Dream Team Exabition at The Peres Center For Peace & Innovation
First Place Pitch Competition
HLTH Diverse founders
Israeli femtech innovation leadership award
Top 20 most promising companies